SAN DIEGO--(BUSINESS WIRE)--Dec. 19, 2017--
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be
presenting at the following investor conference and invited investors to
participate via webcast.
J.P. Morgan Healthcare Conference Presentation, San Francisco, California
January 8, 2018 at 3:30 pm Pacific Time
J.P. Morgan Healthcare Conference Question & Answer Session, San
Monday, January 8, 2018 at 4:00 pm Pacific
The webcasts can be accessed in the Investor Relations section
of Illumina's web site under the "company" tab at www.illumina.com.
Illumina is improving human health by unlocking the power of the genome.
Our focus on innovation has established us as the global leader in DNA
sequencing and array-based technologies, serving customers in the
research, clinical and applied markets. Our products are used for
applications in the life sciences, oncology, reproductive health,
agriculture and other emerging segments. To learn more, visit www.illumina.com
and follow @illumina.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171219005230/en/
Source: Illumina, Inc.
Jacquie Ross, CFA